These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8377367)

  • 41. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The search for the ideal positive inotropic agent.
    Packer M
    N Engl J Med; 1993 Jul; 329(3):201-2. PubMed ID: 8515793
    [No Abstract]   [Full Text] [Related]  

  • 43. [Heart failure and acute myocardial infarct. Current treatment].
    Bernard R; Renard M
    Bull Mem Acad R Med Belg; 1983; 138(11):534-43. PubMed ID: 6679446
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 45. Apelin has in vivo inotropic effects on normal and failing hearts.
    Berry MF; Pirolli TJ; Jayasankar V; Burdick J; Morine KJ; Gardner TJ; Woo YJ
    Circulation; 2004 Sep; 110(11 Suppl 1):II187-93. PubMed ID: 15364861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drugs for chronic heart failure.
    Treat Guidel Med Lett; 2012 Sep; 10(121):69-72. PubMed ID: 22926426
    [No Abstract]   [Full Text] [Related]  

  • 47. Patients with advanced heart failure and the effects of levosimendan.
    Song ZZ; Ma J
    Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure].
    Latini R
    Ital Heart J Suppl; 2001 Jan; 2(1):83-4. PubMed ID: 11216088
    [No Abstract]   [Full Text] [Related]  

  • 49. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 50. [Current problems of acute heart failure in cardiology and cardiac surgery].
    Solov'ev GM
    Kardiologiia; 1982 Oct; 22(10):5-10. PubMed ID: 6757522
    [No Abstract]   [Full Text] [Related]  

  • 51. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug therapy today: latest thinking on drug therapy post-MI.
    Rodman MJ
    RN; 1981 Jan; 44(1):74-96. PubMed ID: 6905260
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
    Chatterjee K; Wolfe CL; DeMarco T
    Cardiol Clin; 1994 Feb; 12(1):63-72. PubMed ID: 8181026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Contractile disorders of the heart and calcium].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1992 Oct; 15(10):309-11. PubMed ID: 1406441
    [No Abstract]   [Full Text] [Related]  

  • 55. [New drugs with positive inotropic action].
    Bijak A; Czołpiński T
    Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
    [No Abstract]   [Full Text] [Related]  

  • 56. Update of recent clinical trials in heart failure and myocardial infarction.
    Richardson M; Cockburn N; Cleland JG
    Eur J Heart Fail; 1999 Mar; 1(1):109-15. PubMed ID: 10937988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Phosphodiesterase inhibition as a new positive-inotropic principle].
    Hartmann A; Saeed M; Sütsch G; Bing RJ
    Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1971-7. PubMed ID: 3539571
    [No Abstract]   [Full Text] [Related]  

  • 58. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice].
    Rohde LE; Ribeiro JP
    Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential deleterious effects of inotropic agents in the therapy of chronic heart failure.
    Katz AM
    Circulation; 1986 Mar; 73(3 Pt 2):III184-90. PubMed ID: 2417747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.